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ABSTRACT   
Karyotype and array Comparative Genomic Hybridization (a-CGH) are routinely used to identify 
genetic determinants of major congenital malformations (MCMs) in fetal deaths or terminations of 
pregnancy after prenatal diagnosis. Pathogenic rearrangements are found with a variable rate of 9 to 
39% for a-CGH. We collected 33 fetuses, nine with a single MCM and 24 with MCMs involving 
two to four organ systems. Array-CGH revealed Copy Number Variants (CNVs) in 14 out of 33 (42 
%) cases. Eight were classified as pathogenic: this equals a detection rate of 24% (8/33) considering 
fetuses with one or more MCMs, and 33% (8/24) taking into account fetuses with multiple 
malformations only. Three of the pathogenic variants were known microdeletion syndromes 
[22q11.21 deletion, central chromosome 22q11.21 deletion and Thrombocytopenia Absent Radius 
(TAR) syndrome] and five were large rearrangements, amounting up to >11 Mb per subject, and 
spanning strong phenotype-related genes. One of those was a de novo complex rearrangement. The 
remaining four duplications and two deletions were 130-900 kb in size, containing 1 to 7 genes, and 
were classified as variants of unknown clinical significance (VOUS). Our study confirms a-CGH as 





There is no consensus for defining major and minor Congenital Malformations (CMs). Commonly 
accepted definitions describe major anomalies (MCM) as “anatomic abnormalities that are severe 
enough to reduce life expectancy or compromise normal function”. Minor anomalies are “unusual 
morphologic features that are of no serious medical or cosmetic consequence to the patient”. They 
may be indicative of a more generalized altered morphogenesis or may represent a valuable 
indication for identifying a specific malformative syndromes (Kennet 2005; Kumar and Burton 
2007). 
Data from the EUROCAT network established a prevalence of MCMs in Europe of 2.6% between 
2008 and 2012, including live births (2.1%), and fetal deaths/terminations of pregnancy after 
prenatal diagnosis (0.5%). Around 18% of MCMs were ascribed to known genetic conditions 
(http://www.eurocat-network.eu).  
The genetic etiology of MCMs is widely variable: monogenic syndromes are estimated to account 
for 2-10% of cases, whereas chromosomal abnormalities are found in 10-15% of liveborn with 
MCMs (Stevenson 2006) and in 9-39% of fetuses with abnormal ultrasound findings, depending on 
the presence of a single anomaly or multiple malformations (Rizzo et al. 1996; Saldarriaga et al. 
2015; Tseng et al. 2006; Wilson et al. 1992; Yashwanth et al. 2010). Subtelomeric deletions are 
present in around 5% of patients with multiple CMs associated with mental retardation (Koolen et 
al. 2004). Retrospective studies using array-Comparative Genomic Hybridization (a-CGH) in 
fetuses with multiple malformations report a detection rate of pathogenic chromosomal imbalances 
from 8 to 18% and a 10%-increase in the diagnostic yield of chromosomal microarray over 
karyotyping (95% confidence interval)(de Wit et al. 2014; Hillman et al. 2013; Le Caignec et al. 
2005; Schaeffer et al. 2004; Tyreman et al. 2009; Vialard et al. 2009). It is estimated that ~50% of 
CMs have an unknown etiology (Rajangam and Nanjappa 2007).   
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In this work, we evaluated the detection rate of a-CGH analysis in identifying pathogenic 
chromosomal deletions/duplication in a group of fetuses with single or multiple CMs.  
 
Materials and Methods  
Cases and anatomopathological evaluation 
Between January 2010 and September 2013 at the “Città della Salute e della Scienza di Torino” 
University Hospital, approximately 960 fetuses underwent autopsy following spontaneous 
abortions, intrauterine/neonatal deaths, and Termination Of Pregnancy for Fetal Anomalies 
(TOPFA). Fetal autopsy included evaluation of external appearance, measurement of morphometric 
parameters, examination of thorax and abdominal anatomy, and histological examination of main 
organs and pathological tissues. Skeletal X-ray analysis was performed on each fetus. Fetuses with 
suspicious infective causes of anomalies were excluded by placental examination. Excluding cases 
suggestive of a monogenic disease or a non-genetic origin, we selected 49 fetuses with MCMs. 
Sixteen a-CGH analyses failed due to the inadequate quality of genomic DNA. The remaining 33 
analyses were performed on 9 fetuses with one major malformation and 24 with two or more major 
malformations. The study was approved by the Internal Review Board, and  informed consent was 
obtained from parents of the analyzed fetuses. 
 
Karyotyping and array-CGH analysis 
Karyotyping on GTG-banded chromosomes (≥ 400 bands) was performed on chorionic villus 
sampling, amniotic fluid, or fibroblasts. Genomic DNA was extracted from fetal frozen tissues 
using the DNeasy Blood & Tissue kit (Qiagen, Hilden, Germany) following the manufacturer’s 
instructions. Array-CGH was performed using a 60K whole-genome oligonucleotide microarray 
following the manufacturer’s protocol (Agilent Technologies, Santa Clara, California, USA). Slides 
were scanned using a G2565BA scanner, and analyzed using Agilent CGH Analytics software ver. 
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4.0.81 (Agilent Technologies Inc.) with the statistical algorithm ADM-2 and a sensitivity threshold 
of 6.0. Significant copy-number changes were identified by at least three consecutive aberrant 
probes. Reference human genomic DNA was GRCh37/hg19. We followed pathogenicity criteria for 
CNVs as reported in the reference (Kearney et al. 2011). 
 
Sequencing analysis  
In patient DGT300197, we screened two SNPs in the 5-prime UTR (rs139428292: G>A ) and in the 
first intron (rs201779890: G>C) of the RNA binding motif protein 8A (RBM8A) gene by Sanger 
sequencing. The following PCR conditions were used: 10 µMol primers (5’- gcctttgattggtcagcttg; 
5’- aagggggcggaatctctaat), 200 µMol dNTPs, 60 ng of genomic DNA, and 0.5 unit of KAPA-fast 
2G kit (Kapa Biosystems, Inc., MA, USA) in a 25 µl final volume under standard amplification 
conditions (56°C annealing temperature). PCR products were purified using Agencourt AMPure 
XP-PCR Purification (Beckman Coulter, Miami, FL, USA) and sequenced with the Big Dye v3.1 
kit (Applied Biosystems, Foster City, CA, USA). Products were purified using Agencourt 
CleanSEQ-Dye Terminator Removal (Beckman Coulter) and run on an ABI-3730 platform, using 
the POP7 polymer (Applied Biosystems).  
 
Results  
Standard karyotype analysis was negative on fetal tissue samples, with the exception of nine in 
which the analysis was not possible due to culture failure. Using a-CGH, we identified one or more 
Copy Number Variants (CNVs) in 14 cases (14/33, 42%). Eight were classified as pathogenic: this 
equals to a detection rate of 24% (8/33) considering fetuses with one or more CMs, and 33% (8/24) 
taking in account fetuses with multiple malformations only. Among the eight pathogenic variants, 
three were associated with known microdeletion syndromes: a chromosome 22q11.21 deletion 
syndrome (MIM 188400), a central chromosome 22q11.21 deletion syndrome (Rump et al. 2014), 
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and a Thrombocytopenia Absent-Radius (TAR) syndrome (MIM 274000; Table 1, cases 1-3). The 
majority of TAR patients are compound heterozygous for a deletion on 1q21.1 encompassing the 
RBM8A causative gene, and a low-functioning SNP in either its 5’UTR or intron 1 (Albers et al. 
2012). By sequencing analysis in our TAR case, we identified one of those variants, the 
hypomorphic “C” allele at SNP rs#201779890 on intron 1 of the non-deleted allele.  
In the other five pathogenic CNVs, the extension of the total rearrangements per subject (11-41 
Mb), and the number and the type of genes involved allowed the clear classification of the CNV as 
pathogenic (Table 1, subjects 4-8). 
Cases 4 and 5 are already detailed in (Di Gregorio et al. 2014) as examples of cryptic large CNVs 
(>6 Mb) undetectable by conventional karyotyping.  
Briefly, fetus 4 showed a complex phenotype, displaying partially overlapping features with 
Cornelia de Lange syndrome (MIM 122470). We found two large telomeric rearrangements: a 3q29 
duplication (13.4 Mb) associated with the Cornelia de Lange phenotype (Dundar et al. 2011; Holder 
et al. 1994), and a 15q26.1q26.3 deletion (11.5 Mb) encompassing the minimal region of the 15q26-
qter deletion syndrome (MIM 612626).  
Case 5 carried two duplications on chromosome 7p22.3p22.2 and 7p22.1p21.2, and a deletion of 
chromosome 11q24.1q25. The duplication of the short arm of chromosome 7 causes a characteristic 
pattern of malformations including developmental, craniofacial, skeletal and cardiovascular 
anomalies, the severity of which depends on the size of the duplication (Papadopoulou et al. 2006). 
The neuronal migration defect could be explained by the deletion of Cell Adhesion Molecule-
Related/Downregulated By Oncogenes (CDON, MIM 608707) and Kin of IRRE-like 3 (KIRREL3, 
MIM 607761) on chromosome 11, which are two genes involved in the control of neuronal 
migration and axon guidance (Bhalla et al. 2008; Okada et al. 2006). The cardiac phenotype 
(hypoplastic left heart) is likely to be part of the Jacobsen syndrome spectrum (MIM 147791), due 
to the 11q23 deletion (Grossfeld et al. 2009). 
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In case 6, we found six de novo duplications ranging from 37 kb to 4.8 Mb, with a total of 15.9 Mb, 
involving six different chromosomes. Among these, the 2q31.1 duplication spanned the HOXD 
gene cluster, a family of highly conserved transcription factors involved in the antero-posterior 
development of the limb and in the specification of fingers (Johnson et al. 2003; Johnson et al. 
1998; Kessel and Gruss 1990), and could explain the polydactyly and digital shape anomalies in the 
fetus. Over-expression of HOXD10 in mice cause polydactyly, whereas the duplication of the 
HOXD gene cluster modifies finger-shape and number in mice (Sheth et al. 2007; Tarchini et al. 
2006; Zakany et al. 2004). The other five identified rearrangements could not be clearly related to 
the remaining clinical features. Moreover, a-CGH analysis in parents showed a 1.8 Mb duplication 
on chromosome 2q12.3q13 in his father. 
Case 7 carried a large 13.5 Mb deletion of chromosome 15q25.3q26.3, partially overlapping  with 
the 15q26-qter deletion syndrome region (MIM 612626). This fetus and patients carrying 15q26-
qter deletion show micrognathia, which is part of the Robin sequence (Roback et al. 1991; Tonnies 
et al. 2001). Furthermore, the same region is associated with diaphragmatic hernia, also present in 
our case (MIM 142340)(Castiglia et al. 2005; Klaassens et al. 2007; Klaassens et al. 2005; Mosca et 
al. 2011). IGF1R and ARRDC4 have been identified as the strongest candidates for this phenotype, 
because both are expressed in the developing diaphragm. Nasal bone agenesis could be explained 
by genes in the centromeric segment non-overlapping15q26-qter deletion. 
Case 8 showed a 11.4 Mb deletion on chromosome 3p14.2p13. One of his key features was the 
presence of a congenital heart defect (CHD, Table 1): assessing the pathogenicity of a CNV 
associated with CHD is not always straightforward, as many deletions/duplications encompass 
genes that are not clearly related to cardiac development (Richards and Garg 2010). A notable gene 
present in the deleted region was Forkhead Box P1 (FOXP1, MIM 605515), which is critical for 
heart development and was found to be deleted in a patient with an atrioventricular septal defect 
(Chang et al. 2013). Moreover, a rare contiguous gene syndrome has been described in patients 
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carrying a chromosome 3p14 deletion: key features of this syndrome include short stature, 
dysmorphisms, CHD, developmental delay, urogenital and neurological problems (Dimitrov et al. 
2015). Interestingly, scrotal hypoplasia in the fetus might be explained by the deletion of the 
Prokineticin 2 gene (PROK2, MIM 607002), whose point mutations cause Kallmann syndrome type 
4 (Dode et al. 2006), a disease featuring hypogonadotropic hypogonadism with testicular/scrotal 
atrophy (MIM 610628). A second candidate was the testis-expressed G-protein coupled receptor 27 
(GPR27, MIM 605187), whose function is still poorly defined. Clenched hands in the fetus could be 
explained by the deletion of Forkhead Box Protein P1 (FOXP1) as hypothesized in a patient with 
limb contractures, speech delay, hypertonia and blepharophimosis carrying a 785-kb de novo 3p14 
deletion: FOXP1 haploinsufficiency may be involved in defects of motor neuron development 
resulting in limb contractures (Pariani et al. 2009).  
Among the analyzed fetuses 6/33 (18%) carried CNVs ranging from 130-900 kb (four duplications 
and one deletion), classified as variants of unknown clinical significance (VOUS), which contained 
1-7 genes. Segregation of the identified variants could not be assessed. In these regions, no obvious 
candidate gene could be associated with fetuses clinical features.  
 
Discussion 
In the recent years, about twenty studies have examined the potential impact/pathogenicity of CNVs 
in fetal malformations in prenatal diagnostic setting or after terminations of pregnancy (de Wit et al. 
2014; Papoulidis et al. 2015; Srebniak et al. 2015). The proportion of clinically relevant findings is 
highly variable (from 4.3 to 18%) (de Wit et al. 2014; Papoulidis et al. 2015; Srebniak et al. 2015)  
reaching 24% with our study. Discrepancies among studies may be due to different technical 
platforms, different selection criteria, the size of the sample or the inclusion of VOUS among the 
identified CNVs. Based on the reported data, selection criteria are particular relevant: among our 24 
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cases with multisystem anomalies (2 to 4 organ systems), we found 13 cases with a positive a-CGH 
result (54%), and eight of these had true pathogenic variants (33%).  
Notably, four of the eight cases carried at least one rearrangements above 10 Mb, which was 
undetected by conventional chromosomal analysis. Their loss may be due to the low karyotype 
resolution on chorionic villi or fetal fibroblasts, or to cryptic rearrangements as described by (Di 
Gregorio et al. 2014). Indeed, in a recent meta-analysis such large anomalies were excluded from 
the reported results, lowering the percentage of a-CGH detection (de Wit et al. 2014). Using these 
criteria, we would estimate a 15% of pathogenic copy number variations detected by a-CGH, in line 
with published data.   
We classified as VOUS all the rearrangements without obvious biological effect, absent in the DGV 
database, and/or those for which it was not possible to perform segregation analysis. 
Our results showed a higher percentage of VOUS in comparison to reported studies, where the 
detection rate ranged from 0.5 to 1.7% (Brady et al. 2014; Papoulidis et al. 2015). This discrepancy 
may be due to: 1) VOUS definition, considering that some group does not report rearrangements 
containing no genes (Brady et al. 2014); 2) array resolution (e.g., BAC array vs. oligonucleotide-
array); 3) lack of knowledge about de novo vs. inherited VOUS, which are often considered benign 
if inherited from an healthy parent, especially if gene-devoid; 4) the presence of pathogenic copy 
number variants among VOUS: two of the detected VOUS were >500 kb, above an indicative limit 
of pathogenicity of 400 kb (Miller et al. 2010) and one contained 7 genes.  
 
Genetic counseling to couples after termination of pregnancy due to a fetal malformation is 
particularly difficult. Phenotypic diagnosis is often impossible, and karyotype analysis has a limited 
detection rate.  
Array-CGH data in our report demonstrate that the presence of pathogenic CNVs can allow a more 
precise evaluation of the recurrence risk. This was particularly important for cases in which the 
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derivative of a cryptic rearrangement present in one of the parents was identified (cases 4 and 5), or 
for the known 22q11.21 and TAR syndromes (cases 1, 2 and 3), which are associated with a 
significant recurrence risk, giving the possibility of an early prenatal test in subsequent pregnancies.  
Array-CGH using genomic DNA allows overcome tissue culture difficulties and the low resolution 
of prenatal/fetal karyotypes. Furthermore, balanced rearrangements undetectable at a-CGH (e.g., a 
translocations/insertions) are very unlikely causes of fetal malformations,  suggesting this method to 
be suitable as a first tier analysis (Astbury et al. 2004). However, given the high cost of the 
technique PCR-based Rapid Aneuploidy Detection should be recommended before a-CGH.  
 
In conclusion, we confirm a-CGH as a powerful technique to identify pathogenic chromosomal 
rearrangements in fetuses with MCMs, with a higher detection rate proportional to MCMs severity.  
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Prenatal Echography / Autopsy Karyoty
pe 
a-CGH result Size MIM 






No echography /   Pericerebellar and 
intraventricular hemorrhage, Situs 
ambiguous, Complex cardiopathy  




Oligohydramnios, Right renal agenesis, 
Multicystic left kidney dysplasia /   
Potter facies, Right renal agenesis,  
Multicystic left kidney dysplasia  




Bilateral upper limb bone 
malformations with agenesis of radius 
and ulna, Hands hyperflexion /    Brain 
micro-hemorrhagic foci, Dysmorphic 
features, Bilateral upper limb bone 
malformations (radius agenesis, 
dysplastic and shorten ulna), Scoliosis, 
Supernumerary ribs 




Intrauterine growth retardation, 
Abnormality of the ventricular septum,  
Cardiomegaly, Hyperechogenic bowel 
/  Possible lissencephaly, Lower lip 
protrusion, Micrognathia,   
Abnormality of the ventricular septum,  
Ventriculomegaly, Arm hypoplasia 
46,XX arr 3q27.1q29(184,428,168 - 197,840,339)x3 13.4 Mb 75/18 Pathogenic 
arr 15q26.1q26.3(90,857,664 - 102,383,473)x1 11.5 Mb 27/10 
5  
DGT290945 
No echography /  Agenesis of corpus 
callosum, Abnormality of neuronal 
migration, Abnormality of vertebrae, 
Flat nose, Low set ears, Hypertelorism, 
Aortic arch hypoplasia, Hypoplastic 
left heart, Hypoplastic long bones 
46,XX arr 7p22.3p22.2 (92,532-4,176,031)x3 4 Mb 26/5 Pathogenic 
arr 7p22.1p21.2 (7,044,310-15,709,683)x3 8.6 Mb 16/2 
arr 11q24.1q25(122,467,330-134,868,407)x1 12.4 Mb 57/18 
6  
DGT308533 
Ambiguous genitalia, Penoscrotal 
hypospadias /  Hyploplasia of the 
mandible, Hand polydactyly, Kidney 
dysplasia, Ambiguous genitalia with 
male gonads, Periportal fibrosis, 
Pancreatic hyperplasia, Anal atresia 
46,XY  arr 2q31.1(176,958,852-176,996,671)x3 37 Kb - Pathogenic 
arr 8q24.3(142,205,751-145,747,468)x3 3.5 Mb 58/13 
arr 10q26.3(133,749,950-135,276,555)x3 1.5 Mb 16/2 
arr 11p15.5p15.4(218,365-3,243,604)x3 3 Mb 68/19 
arr 16p13.3(106,271-4,902,543)x3 4.8 Mb 131/24 
arr 20q13.3(60,112,364-62,893,189)x3 2.7 Mb 51/7 
7  
DGT308538 
No echography /   Pierre-Robin 
sequence, Agenesis of the nasal bone, 
Left diaphragmatic hernia  
46,XX arr 15q25.3q26.3(87,344,281-100,872,951) x1 13.5 Mb 46/12 Pathogenic 
15 
 
 8  
DGT308536 
Truncus arteriosus,  Abnormality of the 
ventricular septum  /  Truncus 
arteriosus,  Abnormality of the 
ventricular septum,  Hand clenching, 
Scrotal hypoplasia 
46,XY arr 3p14.2p13(61,067,122-72,423,962)x1 11.4 Mb 23/6 Pathogenic 
9 
DGT301136 
Intrauterine growth retardation /  
Dysmorphic features,  Abnormality of 
vertebrae,  Pulmonary hypoplasia, 
Bilateral renal agenesis, Aplasia of the 




arr 1p31.1(77,444,894-77,578,846)x3 0.13 Mb 2/0 VOUS 
10 
DGT301192 
No echography / Potter facies, Patent 
ductus arteriosus, Vertebral fusion, 
Anal atresia 
46,XY arr 2p22.2(38,523,015-38,570,650)x3 0.47 Mb 1/0 VOUS 
11  
DGT301190 
No echography /  Potter facies, Lower 
limbs hypoplasia, Tibial torsion, 
Fibular aplasia,  Talipes equinovarus 
and oligodactyly 
46,XY arr 2p23,1(30,814,684-30,832,151)x1 0.18 Mb 1/0 VOUS 
12 
DGT301184 
Anhydramnios, Bilateral renal agenesis 
/    Bilateral renal agenesis,  Patent 
ductus arteriosus, Abnormality of the 
ventricular septum, Lower limbs 
hyperextension 
46,XX arr 3q25.1(150,651,708-151,542,568)x3 0.9 Mb 7/2 VOUS 
13  
DGT308540 
No Echography /   Dysmorphic 
features,  Complex cardiac 
malformation, Polysplenia, Unilateral 
renal agenesis, Aplasia of the bladder, 
Ambiguous genitalia, Arms 
malformations, Anal atresia, Limb 
malformations, Oligodactyly, 
Syndactyly 
46,XY arr 5p11q11.1 (49,690,172-50,123,913)x3 0.5 Mb 2/0 VOUS 
14  
DGT312082 
No Echography /  Cerebellar vermis 
hypoplasia,  Rhombencephalosynapsis, 
Subcutaneous edema,  Aortic arch and 
aortic ductus defect 
 
46,XY arr 22q11.23(25.664.618-25.799.582)x1 
 
0.14 Mb 2/0 VOUS 
